Clinical Laserthermia (Sweden) Performance
| CLS-B Stock | SEK 4.36 0.14 3.11% |
The firm shows a Beta (market volatility) of -1.14, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Clinical Laserthermia are expected to decrease slowly. On the other hand, during market turmoil, Clinical Laserthermia is expected to outperform it slightly. At this point, Clinical Laserthermia has a negative expected return of -0.22%. Please make sure to confirm Clinical Laserthermia's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Clinical Laserthermia performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Clinical Laserthermia Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 11.9 M | |
| Total Cashflows From Investing Activities | -408 K |
Clinical |
Clinical Laserthermia Relative Risk vs. Return Landscape
If you would invest 554.00 in Clinical Laserthermia Systems on August 27, 2024 and sell it today you would lose (118.00) from holding Clinical Laserthermia Systems or give up 21.3% of portfolio value over 90 days. Clinical Laserthermia Systems is generating negative expected returns and assumes 5.5592% volatility on return distribution over the 90 days horizon. Simply put, 49% of stocks are less volatile than Clinical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Clinical Laserthermia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clinical Laserthermia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Clinical Laserthermia Systems, and traders can use it to determine the average amount a Clinical Laserthermia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0398
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLS-B |
Estimated Market Risk
| 5.56 actual daily | 49 51% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Clinical Laserthermia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clinical Laserthermia by adding Clinical Laserthermia to a well-diversified portfolio.
Clinical Laserthermia Fundamentals Growth
Clinical Stock prices reflect investors' perceptions of the future prospects and financial health of Clinical Laserthermia, and Clinical Laserthermia fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clinical Stock performance.
| Return On Equity | -2.59 | |||
| Return On Asset | -0.66 | |||
| Operating Margin | (23.95) % | |||
| Current Valuation | 73.29 M | |||
| Shares Outstanding | 134.52 M | |||
| Price To Earning | (10.13) X | |||
| Price To Book | 4.26 X | |||
| Price To Sales | 28.92 X | |||
| Revenue | 2.25 M | |||
| EBITDA | (54.42 M) | |||
| Cash And Equivalents | 13.5 M | |||
| Cash Per Share | 0.39 X | |||
| Total Debt | 100 K | |||
| Debt To Equity | 3.20 % | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (66.17 M) | |||
| Earnings Per Share | (1.08) X | |||
| Total Asset | 66.74 M | |||
| Retained Earnings | (88 M) | |||
| Current Asset | 22 M | |||
| Current Liabilities | 8 M | |||
About Clinical Laserthermia Performance
Assessing Clinical Laserthermia's fundamental ratios provides investors with valuable insights into Clinical Laserthermia's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Clinical Laserthermia is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.Things to note about Clinical Laserthermia performance evaluation
Checking the ongoing alerts about Clinical Laserthermia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clinical Laserthermia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clinical Laserthermia generated a negative expected return over the last 90 days | |
| Clinical Laserthermia has high historical volatility and very poor performance | |
| The company reported the revenue of 2.25 M. Net Loss for the year was (63.62 M) with loss before overhead, payroll, taxes, and interest of (3.63 M). | |
| Clinical Laserthermia Systems has accumulated about 13.5 M in cash with (66.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39. |
- Analyzing Clinical Laserthermia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clinical Laserthermia's stock is overvalued or undervalued compared to its peers.
- Examining Clinical Laserthermia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clinical Laserthermia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clinical Laserthermia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clinical Laserthermia's stock. These opinions can provide insight into Clinical Laserthermia's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.